Cambrian Stock
HealthTechLooking to sell Cambrian stock or options?
Cambrian specializes in developing a portfolio of medicines aimed at addressing the root causes of age-related diseases. The company is focused on creating therapies and medications that initially target specific illnesses, with the ultimate goal of using them as preventive treatments to enhance quality of life. Cambrian empowers scientists to transition their discoveries from the laboratory to clinical settings, ensuring that essential medicines reach patients in need.
Investors Include:
Brenton Saunders, FJ Labs, Care Bear, Amar Hussain, Infinitas Capital, Longevity Vision Fund, Alumni Ventures, Future Ventures (San Francisco), Apeiron Investment Group, TA Ventures.